Use questionnaire

Get started

We designed SPUR for the continuous exploration and optimization of interventions for patients’ adherence to treatment protocols. Our behavioral diagnostic tool SPUR is now free for use by the academic community globally, and the team provides full support.

To start using SPUR, please contact our team and get a response within 48 hours: This email address is being protected from spambots. You need JavaScript enabled to view it.

Translations

The SPUR questionnaire's psychometric properties were tested and subsequently validated in,

English, in the United States and in the United Kingdom,
French,
Mandarin.

If you are interested in using the tool in another language, please reach out to us and we will help facilitate that process with our translation validation service, Mapi Research Trust.

Download information packet

SPUR guide preview

Email *

How did you hear about SPUR? *

If you are interested in using SPUR in your research, please describe briefly the pathology, geography and context of the research.

* I consent to the processing of my personal data.

* I acknowledge the document is for information-purposes only. I pledge not to use the questionnaire without obtaining a license for use.

I would like to subscribe to the bi-monthly Health Behavior Newsletter.

We are processing this data per your request only. We are hosting the data internally. We will not share it. This information will be used to send you information from the author's team, and you will not subscribed to any newsletters other marketing materials. We store the data for maximum of 3 years on secure servers. You can find out how to send a request to access your data, request to delete your data, correct any inaccuracies or restrict our processing of your data. You have the right to lodge a complaint about the way we handle your data with French Data Protection authority CNIL or you can contact our DPO at This email address is being protected from spambots. You need JavaScript enabled to view it. for more information or with concerns. Please view our privacy policy.

Subscribe to our newsletter

Receive our news